Yubo International Biotech Limited (YBGJ)

Market Cap	10.78M
Revenue (ttm)	-18.00
Net Income (ttm)	-1.83M
Shares Out	119.82M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,800
Average Volume	4,022
Open	0.0900
Previous Close	0.0900
Day's Range	0.0710 - 0.1020
52-Week Range	0.0310 - 0.5439
Beta	0.84
RSI	61.73
Earnings Date	Aug 11, 2025

About YBGJ

Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. Yubo International Biotech Limited is headquartered in Beijing, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• CEO: Yang Wang
• Employees: 18
• Stock Exchange: OTCMKTS
• Ticker Symbol: YBGJ

Financial Performance

In 2024, YBGJ's revenue was $3,470, a decrease of -99.43% compared to the previous year's $604,676. Losses were -$1.78 million, 48.6% more than in 2023.